Local research. Human connections. WCR Miami Lakes (786) 483-7856
Back to study searchNCT02202681
By invitationNCT02202681ClinicalTrials.gov record

Imaging the Duodenum Using an Optical Frequency Domain Imaging OFDI Capsule

Celiac Disease · Healthy

THE QUICK READ

What this study involves

The registry does not currently label this study as recruiting. Ask about its status before planning a screening visit.

Study type
Interventional
Phase
Not applicable
Age range
16 years - Not specified
Sex eligible
All sexes
Healthy volunteers
Accepted
Participants
108 Estimated

These are starting points, not an eligibility decision. The research team must review the full requirements.

About the research

The study is being done to assess the tolerability and feasibility of a tethered OFDI capsule to image the duodenum.

A total of 108 participants (36 healthy and 72 with clinically suspected or diagnosed Celiac disease) will be asked to swallow the tethered capsule, while they are awake and unsedated and ask for their feedback. Images will be taken using the OFDI system while the capsule travels from the esophagus into the stomach and into the duodenum.

Read the full description

Participants including healthy volunteers as well as patients with Celiac disease will be recruited and asked to swallow the OFDI capsule while being awake and unsedated. The capsule is attached to a tether which allows the operator to control as well as navigate the capsule as it progresses down the esophagus, through the stomach and into the duodenum using natural propulsive force called peristalsis.

As the capsule progresses, multiple 2-dimensional cross-sectional images of the duodenum are acquired. Images are analyzed at a later stage.

Who may be able to participate?

The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.

Inclusion Criteria:

  • Participant must be over 18 years for healthy volunteers
  • Participants must be over 16 years for patients with Celiac disease
  • Participant must be able to give informed consent

Exclusion Criteria:

  • Participants with an inability to swallow pills or capsules.
  • Participants with esophageal or intestinal fistulas.
  • Participants with known esophageal or intestinal strictures resulting in a luminal diameter smaller than the diameter of the capsule.
  • Participants with a history of intestinal Crohn's disease.
  • Women who are pregnant.
Understand screening

Treatment, groups and participation

The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.

Assignment
Not applicable
Masking
No masking
OFDI Capsule Imaging

Participant will swallow the OFDI Capsule and imaging will be performed using the OFDI system.

Device: OFDI Capsule

OFDI Capsule DEVICE

Imaging of the duodenum with the OFDI capsule and system

Prepare your questions

What researchers are measuring

Outcome measures describe what is being studied. They are not proof that a treatment works.

Primary measures

Tolerability of OFDI Imaging in subjects swallowing the OFDI capsule

Time frame: Images will be acquired during the OFDI imaging session which should on average take anywhere from 30 minutes to 2 hours.

After participating in the study, the participant will be asked for feedback about tolerability of the procedure using a questionnaire.

Feasibility of OFDI Imaging in subjects swallowing the OFDI capsule

Time frame: Images will be acquired during the OFDI imaging session which should on average take anywhere from 30 minutes to 2 hours

An investigator will assess the quality of the recorded images and movies obtained with each exam after the imaging is completed.

No results are flagged as posted.

Review the complete result tables and limitations in the official record.

Open official results ↗

Research locations (1)

The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.

1 locations

Massachusetts General HospitalBoston, Massachusetts, United StatesStatus unknown

Study team and timeline

Lead sponsor
Massachusetts General Hospital
Study start
Sep 16, 2013 Actual
Primary completion
Oct 28, 2028 Estimated
Study completion
2030-07 Estimated
First posted
Jul 29, 2014 Estimated
Last updated
Nov 10, 2026 Actual

Official study contacts

No central contact is listed. Check the locations and the official record.

Official study title

Pilot Study for Imaging of the Duodenum Using an OFDI Capsule

A HUMAN NEXT STEP

Ask Wellness Clinical Research

Your message goes to WCR, including when this study is run by another organization. WCR may offer general guidance but may not operate this trial, have access to its team or be able to enroll you.

Please do not include medical records, diagnoses, medications, insurance numbers or other sensitive details. This form is for general questions, not urgent care.

Sending a question does not enroll you in a trial.

Source: ClinicalTrials.gov API v2. Information is submitted by sponsors and investigators. NLM does not approve the safety or science of all listed studies. Registry disclaimer.

Retrieved: Nov 11, 2026 · Last registry update: Nov 10, 2026